MoonLake Stock (NASDAQ:MLTX), Quotes and News Summary

Q: What sector and industry does MoonLake (MLTX) operate in?

MoonLake is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

MoonLake Stock (NASDAQ: MLTX) stock price, news, charts, stock research, profile.

Open	$43.600
Close	$42.430
Volume / Avg.	273.377K / 475.483K
Day Range	41.800 - 43.600
52 Wk Range	19.800 - 64.980
Market Cap	$2.668B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	37
Short Interest	22.35%
Days to Cover	13.82

Recent News

Why Is Inflammatory Disease-Focused MoonLake Immunotherapeutics Stock Trading Higher Today?

Results with MoonLake Immunotherapeutics' Nanobody sonelokimab in Psoriatic Arthritis. Achieve over 60% ACR50, 40% ACR70, and 80% PASI90 by week 24. Unprecedented improvements compared to competitors.

Vandana Singh

Cooper Companies Reports Upbeat Results, Joins Dell, NetApp, Tidewater And Other Big Stocks Moving Higher On Friday

U.S. stocks were higher, with the Nasdaq Composite gaining around 0.5% on Friday.

Avi Kapoor

Dow Turns Lower; EchoStar Shares Plunge

U.S. stocks turned lower toward the end of trading, with the Dow Jones falling around 50 points on Monday The Dow traded down 0.16% to 34,007.81 while the NASDAQ fell 0.08% to 13,467.42. The S&P 500 also fell, dropping, 0.13% to 4,352.49.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Nov 23

Dec 23

Feb

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About MoonLake Immunotherapeutics

Sector

Health Care

Industry

Biotechnology

MoonLake Immunotherapeutics is a clinical-stage biotechnology company engaged in leveraging Nanobody...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy MoonLake (MLTX) stock?

You can purchase shares of MoonLake (NASDAQ: MLTX) through any online brokerage.

View our list of the best stock brokerages.

Who are MoonLake's (MLTX) competitors?

Other companies in MoonLake’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), SpringWorks Therapeutics (NASDAQ:SWTX), TG Therapeutics (NASDAQ:TGTX), Arrowhead Pharma (NASDAQ:ARWR) and Apogee Therapeutics (NASDAQ:APGE).

What is the target price for MoonLake (MLTX) stock?

The latest price target for MoonLake (NASDAQ: MLTX) was reported by HC Wainwright & Co. on Tuesday, April 23, 2024. The analyst firm set a price target for 100.00 expecting MLTX to rise to within 12 months (a possible 135.68% upside). 47 analyst firms have reported ratings in the last year.

Current Stock Price for MoonLake (MLTX)?

The stock price for MoonLake (NASDAQ: MLTX) is $42.43 last updated April 24, 2024 at 4:00 PM EDT.

Does MoonLake (MLTX) pay a dividend?

There are no upcoming dividends for MoonLake.

When is MoonLake (NASDAQ:MLTX) reporting earnings?

MoonLake’s Q1 earnings are confirmed for Friday, May 10, 2024.

Is MoonLake (MLTX) going to split?

There is no upcoming split for MoonLake.

What sector and industry does MoonLake (MLTX) operate in?

MoonLake is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-